Can you really get a Windows PC running like new again? Using this free tool from Microsoft, you can get pretty close.
Stop struggling with complex VPNs and risky port forwarding. Netbird gives you instant, secure remote access to your self-hosted apps in minutes.
When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...
In Oregon and Colorado, you can book an appointment for psilocybin therapy, where a licensed therapist takes you on a guided trip using the drug that makes “magic” mushrooms hallucinogenic. Host Flora ...
Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...
Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...
Microsoft's PC Manager promises to optimize your machine's performance at no cost. I tried it out to see if it's good enough to replace third-party tools.
Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...
If a user opened this Markdown file in Windows 11 Notepad versions 11.2510 and earlier and viewed it in Markdown mode, the above text would appear as a clickable link. If the link is clicked with ...
Current school board member Rae Gallagher said she hopes to continue preserving protections and programs for students in her reelection run for the Frederick County Board of Education. She said she ...
Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results